...has more than 100 years of combined experience along the value chain and is continuously pioneering the German cannabis market.
Daniel Kruse, a pioneer in the hemp industry since 1995, is Managing Director (CEO) of SynBiotic SE and founder of Hempro International GmbH, Hemp Factory GmbH, MH medical hemp GmbH, Hemp Farm GmbH and HempConsult GmbH, five of Europe's leading hemp companies. Since 2013, Daniel Kruse has served as a board member of the European Industrial Hemp Association (EIHA) and was elected president in 2019. Kruse is also vice chairman of the Federation of International Hemp Organizations (FIHO).
Rebecca Kruse has been working for Hempro International in the marketing department and product development since completing her studies in economics in 2006. As a trained businesswoman, she gained valuable experience in the business world and the international hemp market through these many years of work and is therefore an expert in all topics related to brand management as well as product positioning. Further focal points of her work are finances, internal organization and communication. She is a specialist for controlling, data analysis as well as process optimization. For many years she has managed the companies Hempro Int. and Hemp Factory as Managing Director. Since 2023 Rebecca is Head of Finance at SynBiotic SE.
Lars Müller is an experienced multi-entrepreneur with over 15 years of experience in building companies in growth markets. Among others, Lars is the founder and CEO of Solidmind Group GmbH and Lean Labs Pharma GmbH.
As one of the leading experts in Germany, he is valued for his in-depth industry know-how from seed development to product positioning, genetics, extraction methods and analytics as well as product development. He has been in the cannabinoid business since 2015 and takes a holistic approach from cultivation to shelf presentation.
Johannes Gallois is founder of SynBiotic Distribution (formerly GECA Pharma GmbH), one of the first distributors of medical cannabis in Germany. He has more than 12 years of leadership, retail and distribution experience in international markets for FMCG, lifestyle and healthcare products.
Joscha Krauß is the CEO of MH medical hemp GmbH. He holds an M.Sc. in Ecology and is a graduate of the MasterClass of the Dutch medicinal hemp producer Bedrocan. He is on the board of the Brussels-based association Medicinal Cannabis Europe and the German Cannabis Trade Association (BvcW).
Rafael Dulon is one of the best known and most experienced experts in industrial hemp cultivation in Europe. He has been contract growing industrial hemp with farmers and cooperatives since 1997. Rafael Dulon is co-founder and CEO of the Germany-based HANF FARM GmbH.
Tax specialist, since 2018 of Solidmind Group GmbH and Lean Labs Pharma GmbH. Joined the management team at Group level in the Finance & Controlling department in early 2023. Her tasks include the preparation of the consolidated financial statements, all reporting and liquidity planning.
Master in Business Administration/Management, over 10 years of expertise in sales, marketing, business development and restructuring. Since 2019 in the cannabis industry at Solidmind Group GmbH as a member of the management board. From 2023 in the management team of SynBiotic SE with focus on projects and synergies, new business concepts and management of the Ventures Solidmind Group GmbH and Cannexo GmbH.
Banking specialist and bachelor's degree in business administration/management. Since 2016 manager of Solidmind Group GmbH and Lean Labs Pharma GmbH as authorized representative and COO.
Since spring 2023, Lukas has been working in the management team at Group level in the Projects & Synergies department. His responsibilities include the management of research and development projects as well as the synergetic consolidation of the various investments.
With over a decade of experience as a business and marketing leader, including building one of Germany's largest financial communities, he joined the management of SynBiotic SE in 2021. Responsible for internal and external communications, he focuses on developing, retaining, and expanding the company's network. Additionally, he oversees the marketing strategies of various ventures within the group, concentrating on creating a synergistic marketing dynamic that enhances the reach and influence of SynBiotic SE as a whole.
Oliver Conrad, Managing Partner at AHW Hunold & Partner in Cologne since 2023. Certified tax advisor since 2014, appointed auditor in 2015. Expertise in national and international accounting, due diligence, financial process optimization, risk management, tax compliance, annual audit, company valuation and special economic audit. Member of IDW, Chamber of Auditors and Chamber of Tax Advisors NRW. Experience in biotechnology, pharmaceutical industry, chemicals, aviation, trade and services. Previous Big Four experience as a director.
Rainer Seiler is a healthcare market consultant and entrepreneur. He develops and implements value-creating business models, supply projects and selective contracts, primarily in the pharmaceutical sector. Currently supporting international companies in Market Access, Sales and Digital Health, he brings extensive industry experience to several healthcare companies. He has 20 years of leadership experience in pharmaceuticals, pharmacies, eCommerce and wholesale, including as Managing Director at the Swiss Zur Rose Group (including DocMorris). His professional books cover topics such as patient centricity, healthcare innovation and managed care. He is also active in various health-related organizations, including as co-founder of the non-profit initiative Pflasterpass, which is dedicated to first aid for children.
Frank Otto is a German multi-entrepreneur and a major shareholder of SynBiotic SE through his investment in CannaCare Health GmbH. With many years of experience in the media business, he is a co-founder of various companies in the healthcare market. Frank Otto has been actively involved in environmental and social projects in Hamburg and pursues the goal of linking economic success with sustainable action, especially in the field of cannabis.
Bruce Linton is the founder and former CEO and Chairman of Canopy Growth Corporation, one of the world's largest cannabis-focused companies. Bruce Linton is currently a member of the board of Creso Pharma, co-chairman and former CEO of Martello Technologies Group Inc. and chairman of the advisory board of Red Light Holland Corp. He is also an advisor to Celadon Pharmaceuticals and Above Foods.
.png)
Dr. Thomas Haffner has more than 25 years of experience in thepharmaceutical industry, especially in product development and internationallicensing. He is a leading expert in the conception and marketing of OTC drugs,project management and consultant to successful drug manufacturers.
Christian Angermayer is the founder of Apeiron Investment Group, his own family office focusing on biotech, fintech and deep tech. Among many other companies, Christian has founded ATAI Life Sciences AG. It has reached approx. USD 1bn valuation within 2.5 years since foundation.
Michael Auerbach is the general partner and founder of the investment holding Subversive Capital. He is also Chairman of the Californian cannabis platform company Parent Company. Previously he was Director of Tilray. Michael is appreciated as one of the most renowned investors in Cannabis companies worldwide.
Daniel Kruse, a pioneer in the hemp industry since 1995, is Managing Director (CEO) of SynBiotic SE and founder of Hempro International GmbH, Hemp Factory GmbH, MH medical hemp GmbH, Hemp Farm GmbH and HempConsult GmbH, five of Europe's leading hemp companies. Since 2013, Daniel Kruse has served as a board member of the European Industrial Hemp Association (EIHA) and was elected president in 2019. Kruse is also vice chairman of the Federation of International Hemp Organizations (FIHO).
.png)
Lars is a profound serial entrepreneur with over 15 years experience in building sustainable companies.
Lars is the founder and CEO of Solidmind Group GmbH, Lean Labs Pharma GmbH and leads the vision and strategy of the group since 2015.
Johannes Gallois is founder of SynBiotic Distribution (formerly GECA Pharma GmbH), one of the first medical cannabis distributors in Germany. He has more than 12 years of leadership, retail and sales experience in international markets for FMCG, lifestyle and healthcare products.
Joscha Krause is the managing director of MH medical hemp GmbH. He holds a M.Sc. in ecology and is a MasterClass graduate at Dutch medicinal cannabis producer Bedrocan. He is now on the board of the Brussel based association “Medicinal Cannabis Europe“ and the German Cannabis trade association (BvcW).
Rafael Dulon is one of the best-known experts in industrial hemp cultivation in Europe. Since 1997 he has been operating the contract cultivation of industrial hemp with farmers and cooperatives. Rafael Dulon is the founder and managing director of the Germany-based HANF FARM GmbH.
.png)
Bruce Linton is the Founder and former CEO and Chairman of Canopy Growth Corporation, one of the world's largest Cannabis-focused corporations. Bruce currently holds positions on the Board of Creso Pharma, Co-Chairman and former CEO of Martello Technologies Group Inc., and Chairman of the Advisory Board for Red Light Holland Corp. He is an Advisor with Celadon Pharmaceuticals and Above Foods.
Rainer Seiler has many years of leadership experience, including as Managing Director (Zur Rose Gruppe), as General Sales Manager (ratiopharm) and as Director Key Account Management within the pharmaceutical Industry (Rx, OTC, Gx), as well as with wholesalers and mail-order-pharmacy-companies.
Christian Angermayer is the founder of Apeiron Investment Group, his own family office focusing on biotech, fintech and deep tech. Among many other companies, Christian has founded ATAI Life Sciences AG. It has reached approx. USD 1bn valuation within 2.5 years since foundation.
Michael Auerbach is the general partner and founder of the investment holding Subversive Capital. He is also Chairman of the Californian cannabis platform company Parent Company. Previously he was Director of Tilray. Michael is appreciated as one of the most renowned investors in Cannabis companies worldwide.
Lorem Ipsum Lorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem
Lorem Ipsum Lorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem IpsumLorem
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Suspendisse varius enim in eros elementum tristique.
